| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
B. Riley Securities analyst Craig Ellis maintains Axcelis Technologies (NASDAQ:ACLS) with a Neutral and lowers the price tar...
Axcelis Technologies (NASDAQ:ACLS) is looking for Q4 GAAP EPS of $0.76 vs $0.80 analyst estimate..
Axcelis Technologies (NASDAQ:ACLS) is looking for Q4 Adj EPS of $1.12 vs $0.96 analyst estimate. sees sales of $215.000 million...
Axcelis Technologies (NASDAQ:ACLS) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of ...
B of A Securities analyst Duksan Jang downgrades Axcelis Technologies (NASDAQ:ACLS) from Neutral to Underperform and raises ...
Analyst takes cautious stance on ACLS, cuts rating to Underperform and raises price forecast due to potential of merger with VE...
Berkshire agreed to buy OxyChem for $9.7 billion while EA goes private for $55 billion. Also, Middleby seeks a $800 million deal.